Lung-MAP Newsletter Out Now

November 27, 2017
Communications Manager

The Winter 2017 edition of the newsletter on SWOG's Lung-MAP precision medicine trial is out. Lung-MAP is NCI's first precision trial, and testing new treatments for squamous cell lung cancer.

The newsletter has the latest on a reopened sub-study, a trial update at the World Conference on Lung Cancer last month in Japan, and a December 7 webinar for site staff, who can get the study status and all their questions answered by Lung-MAP leaders on the call. Read the new edition here.

Other Recent Stories

SWOG Front Line banner
The Front Line
Nov 22, 2024

A Further Look at SWOG Radiopharmaceuticals

SWOG's newest subcommittee: Theranostics
SWOG Front Line banner
The Front Line
Nov 15, 2024

More Trials for More Veterans at More VAs in More Communities

SWOG Front Line banner
The Front Line
Nov 8, 2024

Not Your Father’s Oldsmobile’s Dashboard

Our interactive dashboards let you visualize and manipulate data on SWOG's key performance indicators